Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase 1/2 4 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 43 OTHER 34 UNKNOWN 3 NETWORK 3 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Uterine Cervical Neoplasms 11 Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 8 Neoplasms 8 Esophageal Neoplasms 8 Carcinoma, Ovarian Epithelial 7 Fallopian Tube Neoplasms 6 Colorectal Neoplasms 5 Recurrence 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Rectal Neoplasms 3 Nasopharyngeal Carcinoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Glioblastoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Peripheral Nervous System Diseases 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Triple Negative Breast Neoplasms × Clear all

NCT03168880 2025-04-09

TNBC

Tata Memorial Hospital

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡